Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

Nature Biotechnology

Volumn 26, Issue 5, 2008, Pages 571-577

  Chang, David C ^a   Liu, Wen J ^a   Anraku, Itaru ^b   Clark, David C ^a   Pollitt, Christopher C ^a   Suhrbier, Andreas ^b   Hall, Roy A ^a   Khromykh, Alexander A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGY; PROTEINS; TRANSCRIPTION; VACCINES; VIRUSES;

FLAVIVIRUS; IMMUNOGENICITY; INFECTIOUS PARTICLES; VIRUS-LIKE PARTICLES;

DNA;

DNA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE CONSTRUCT; GENE GUN IMMUNIZATION; HORSE; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; RNA TRANSLATION; VERO CELL; VIRUS CAPSID; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS LIKE AGENT; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; WEST NILE FLAVIVIRUS;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; FLAVIVIRUS INFECTIONS; GENE THERAPY; GENETIC VECTORS; MICE; TRANSFECTION; TREATMENT OUTCOME; VACCINES, DNA; VIRION;

EQUIDAE; FLAVIVIRUS; MIRIDAE; MUS; REPLICATION DEFECTIVE VIRUSES; WEST NILE VIRUS;

EID: 43449113254     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1400     Document Type: Article

References (30)

1. Pugachev, K.V., Guirakhoo, F., Trent, D.W. & Monath, T.P. Traditional and novel approaches to flavivirus vaccines. Int. J. Parasitol. 33, 567-582 (2003).
2. Chang, G.J., Davis, B.S., Hunt, A.R., Holmes, D.A. & Kuno, G. Flavivirus DNA vaccines: current status and potential. Ann. NY Acad. Sci. 951, 272-285 (2001).
3. Phillpotts, R.J., Venugopal, K. & Brooks, T. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol. 141, 743-749 (1996).
4. Konishi, E., Yamaoka, M., Khin Sane, W., Kurane, I. & Mason, P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72, 4925-4930 (1998).
5. Colombage, G., Hall, R., Pavy, M. & Lobigs, M. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250, 151-163 (1998).
6. Kochel, T. et al. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15, 547-552 (1997).
7. Aberle, J.H. et al. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J. Immunol. 163, 6756-6761 (1999).
8. Davis, B.S. et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75, 4040-4047 (2001).
9. Hall, R.A. & Khromykh, A.A. West Nile virus vaccines. Expert Opin. Biol. Ther. 4, 1295-1305 (2004).
10. Anraku, I. et al. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 76, 3791-3799 (2002).
11. Kofler, R.M. et al. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc. Natl. Acad. Sci. USA 101, 1951-1956 (2004).
12. Seregin, A. et al. Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives. Virology 356, 115-125 (2006).
13. Mason, P.W., Shustov, A.V. & Frolov, I. Production and characterization of vaccines based on flaviviruses defective in replication. Virology 351, 432-443 (2006).
14. Hall, R.A., Broom, A.K., Smith, D.W. & Mackenzie, J.S. The ecology and epidemiology of Kunjin virus. Curr. Top. Microbiol. Immunol. 267, 253-269 (2002).
15. Hall, R.A. et al. Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology 264, 66-75 (1999).
16. Hall, R.A. et al. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc. Natl. Acad. Sci. USA 100, 10460-10464 (2003).
17. Co, M.D., Terajima, M., Cruz, J., Ennis, F.A. & Rothman, A.L. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293, 151-163 (2002).
18. Raz, E. et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519-9523 (1994).
19. Pertmer, T.M. et al. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427-1430 (1995).
20. Castillo-Olivares, J. & Wood, J. West Nile virus infection of horses. Vet. Res. 35, 467-483 (2004).
21. Ng, T. et al. Equine vaccine for West Nile virus. Dev. Biol. (Basel) 114, 221-227 (2003).
22. Schlesinger, J.J., Brandriss, M.W., Putnak, J.R. & Walsh, E.E. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J. Gen. Virol. 71, 593-599 (1990).
23. Chung, K.M. et al. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80, 1340-1351 (2006).
24. Khromykh, A.A., Sedlak, P.L. & Westaway, E.G. cis- and trans-acting elements in flavivirus RNA replication. J. Virol. 74, 3253-3263 (2000).
25. Lindenbach, B.D. & Rice, C.M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71, 9608-9617 (1997).
26. Twiddy, S.S. & Holmes, E.C. The extent of homologous recombination in members of the genus Flavivirus. J. Gen. Virol. 84, 429-440 (2003).
27. Monath, T.P. et al. Recombination and flavivirus vaccines: a commentary. Vaccine 23, 2956-2958 (2005).
28. Lindenbach, B.D. & Rice, C. Flaviviridae: the viruses and their replication. in Fields Virology. 4th edn. (eds. Knipe, D.M. & Howley, P.M.) 991-1041 (Lippincott Williams & Wilkins, Philadelphia, 2001).
29. Le, T.T. et al. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs. Vaccine 19, 4669-4675 (2001).
30. Spaulding, A.C., Kurane, I., Ennis, F.A. & Rothman, A.L. Analysis of murine CD8(+) Tcell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J. Virol. 73, 398-403 (1999).